Zimmer Biomet Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Zimmer Biomet (ZBH) PT Raised to $197 at Baird
August 4, 2021 9:02 AM EDTBaird analyst Jeffrey Johnson raised the price target on Zimmer Biomet (NYSE: ZBH) to $197.00 (from $195.00) while maintaining an Outperform rating.
The analyst commented, "A few issues weighed on shares yesterday, including China tender and ZBH market share uncertainties and somewhat sluggish pace of... More
Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 3c
August 3, 2021 6:35 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.90, $0.03 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2.03 billion versus the consensus estimate of $1.98 billion.
"Our performance in the second quarter improved meaningfully from the first quarter 2021 across all... More



